A sixth SAE that was unanticipated and probably related to both study drugs was new onset reactive additive polyarthritis occurring in the wrists, hands, and knees of patient M14 on both plerixafor and G-CSF. This evidence concerns the gene CSF3 and polyarticular arthritis.